KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jan 18, 2017
Insider Transaction Report
Form 4
Carberry Christine A.
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-17+170,000→ 170,000 totalExercise: $6.02Exp: 2027-01-17→ Common Stock (170,000 underlying) - Award
Common Stock (Restricted)
2017-01-17+85,000→ 85,000 total
Footnotes (2)
- [F1]The 85,000 shares are restricted common stock, which will vest over three years with the first one-third vesting on January 17, 2018, and the remaining shares vesting in equal quarterly installments through the third anniversary of the grant date on January 17, 2020.
- [F2]The options vest according to the following schedule: the first one-third of the 170,000 options will vest on January 17, 2018, and the remaining options shall vest in equal quarterly installments through the third anniversary of the grant date on January 17, 2020.